Cover
Cover - shares | 3 Months Ended | |
Mar. 31, 2024 | May 31, 2024 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity Interactive Data Current | Yes | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2024 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q1 | |
Entity Information [Line Items] | ||
Entity Registrant Name | PLUTONIAN ACQUISITION CORP. | |
Entity Central Index Key | 0001929231 | |
Entity File Number | 001-41554 | |
Entity Tax Identification Number | 86-2789369 | |
Entity Incorporation, State or Country Code | DE | |
Current Fiscal Year End Date | --12-31 | |
Entity Current Reporting Status | No | |
Entity Shell Company | true | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Contact Personnel [Line Items] | ||
Entity Address, Address Line One | 1441 Broadway 3rd | |
Entity Address, Address Line Two | 5th & 6th Floors | |
Entity Address, City or Town | New York | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10018 | |
Entity Phone Fax Numbers [Line Items] | ||
City Area Code | (646) | |
Local Phone Number | 969 0946 | |
Entity Listings [Line Items] | ||
Entity Common Stock, Shares Outstanding | 5,000,767 | |
Units, each consisting of one share of Common Stock, one redeemable Warrant, and one right to receive one-sixth (1/6) of a share of common stock | ||
Entity Listings [Line Items] | ||
Title of 12(b) Security | Units, each consisting of one share of Common Stock, one redeemable Warrant, and one right to receive one-sixth (1/6) of a share of common stock | |
Trading Symbol | PLTNU | |
Security Exchange Name | NASDAQ | |
Common Stock, par value $0.0001 | ||
Entity Listings [Line Items] | ||
Title of 12(b) Security | Common Stock, par value $0.0001 | |
Trading Symbol | PLTN | |
Security Exchange Name | NASDAQ | |
Warrant, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share | ||
Entity Listings [Line Items] | ||
Title of 12(b) Security | Warrant, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share | |
Trading Symbol | PLTNW | |
Security Exchange Name | NASDAQ | |
Rights, each right entitling the holder to receive one-sixth (1/6) of one share of Common Stock | ||
Entity Listings [Line Items] | ||
Title of 12(b) Security | Rights, each right entitling the holder to receive one-sixth (1/6) of one share of Common Stock | |
Trading Symbol | PLTNR | |
Security Exchange Name | NASDAQ |
Condensed Balance Sheets
Condensed Balance Sheets - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
Current Assets | ||
Cash | $ 31,453 | $ 425,852 |
Prepaid expenses | 83,902 | 89,472 |
Total Current Assets | 115,355 | 515,324 |
Investments held in Trust Account | 35,627,550 | 34,959,697 |
Total Assets | 35,742,905 | 35,475,021 |
Current Liabilities | ||
Accounts payable and accrued expenses | 562,787 | 196,487 |
Franchise tax payable | 53,600 | 42,800 |
Income tax payable | 229,002 | 505,120 |
Excise tax payable | 262,449 | 262,449 |
Total Current Liabilities | 2,677,838 | 2,016,856 |
Deferred underwriting fee payable | 2,012,500 | 2,012,500 |
Total Liabilities | 4,690,338 | 4,029,356 |
Commitments and Contingencies | ||
Common stock subject to possible redemption, $0.0001 par value; 15,000,000 shares authorized; 3,239,642 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively, at redemption value | 35,353,867 | 34,790,696 |
Stockholders’ Deficit | ||
Common stock, $0.0001 par value; 15,000,000 shares authorized; 1,761,125 shares issued and outstanding (excluding 3,239,642 shares subject to possible redemption at March 31, 2024 and December 31, 2023) | 176 | 176 |
Accumulated Deficit | (4,301,476) | (3,345,207) |
Total Stockholders’ Deficit | (4,301,300) | (3,345,031) |
Total Liabilities, Temporary Equity, and Stockholders’ Deficit | 35,742,905 | 35,475,021 |
Related Party | ||
Current Liabilities | ||
Promissory note | 1,150,000 | 800,000 |
Big Tree Cloud | ||
Current Liabilities | ||
Promissory note | $ 420,000 | $ 210,000 |
Condensed Balance Sheets (Paren
Condensed Balance Sheets (Parentheticals) - $ / shares | Mar. 31, 2024 | Dec. 31, 2023 |
Statement of Financial Position [Abstract] | ||
Common stock subject to possible redemption, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock subject to possible redemption, shares authorized | 15,000,000 | 15,000,000 |
Common stock subject to possible redemption, shares issued | 3,239,642 | 3,239,642 |
Common stock subject to possible redemption, shares outstanding | 3,239,642 | 3,239,642 |
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 15,000,000 | 15,000,000 |
Common stock, shares outstanding | 1,761,125 | 1,761,125 |
Common stock, shares issued | 1,761,125 | 1,761,125 |
Unaudited Condensed Statements
Unaudited Condensed Statements of Operations - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
General and administrative expenses | $ 746,269 | $ 186,240 |
Franchise tax expenses | 10,800 | 12,000 |
Loss from operations | (757,069) | (198,240) |
Interest earned on investment held in Trust Account | 457,853 | 623,637 |
Income (loss) before income taxes | (299,216) | 425,397 |
Income tax provision | (93,882) | (128,444) |
Net income (loss) | $ (393,098) | $ 296,953 |
Redeemable Common Stock | ||
Basic weighted average shares outstanding (in Shares) | 3,239,642 | 5,750,000 |
Basic net income (loss) per share (in Dollars per share) | $ (0.02) | $ 0.15 |
Non-Redeemable Common Stock | ||
Basic weighted average shares outstanding (in Shares) | 1,761,125 | 1,761,125 |
Basic net income (loss) per share (in Dollars per share) | $ (0.19) | $ (0.31) |
Unaudited Condensed Statement_2
Unaudited Condensed Statements of Operations (Parentheticals) - $ / shares | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Redeemable Common Stock | ||
Diluted weighted average shares outstanding | 3,239,642 | 5,750,000 |
Diluted net income (loss) per share | $ (0.02) | $ 0.15 |
Non-Redeemable Common Stock | ||
Diluted weighted average shares outstanding | 1,761,125 | 17,611,251 |
Diluted net income (loss) per share | $ (0.19) | $ (0.31) |
Unaudited Condensed Statement_3
Unaudited Condensed Statements of Changes in Stockholders’ Equity (Deficit) - USD ($) | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Total |
Balance at Dec. 31, 2022 | $ 176 | $ 3,500,598 | $ 122,129 | $ 3,622,903 |
Balance (in Shares) at Dec. 31, 2022 | 1,761,125 | |||
Accretion of common stock to redemption value | (2,615,348) | (2,615,348) | ||
Net income (loss) | 296,953 | 296,953 | ||
Balance at Mar. 31, 2023 | $ 176 | 885,250 | 419,082 | 1,304,508 |
Balance (in Shares) at Mar. 31, 2023 | 1,761,125 | |||
Balance at Dec. 31, 2023 | $ 176 | (3,345,207) | $ (3,345,031) | |
Balance (in Shares) at Dec. 31, 2023 | 1,761,125 | 1,761,125 | ||
Accretion of common stock to redemption value | (563,171) | $ (563,171) | ||
Net income (loss) | (393,098) | (393,098) | ||
Balance at Mar. 31, 2024 | $ 176 | $ (4,301,476) | $ (4,301,300) | |
Balance (in Shares) at Mar. 31, 2024 | 1,761,125 | 1,761,125 |
Unaudited Condensed Statement_4
Unaudited Condensed Statements of Cash Flows - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Cash flows from operating activities: | ||
Net income (loss) | $ (393,098) | $ 296,953 |
Adjustments to reconcile net cash used in operating activities: | ||
Interest earned on investments held in Trust Account | (457,853) | (623,637) |
Changes in current assets and current liabilities: | ||
Prepaid expenses | 5,570 | (26,051) |
Accounts payable and accrued expenses | 366,300 | (23,971) |
Franchise tax payable | 10,800 | 4,862 |
Income tax payable | (276,118) | 128,444 |
Net cash used in operating activities | (744,399) | (243,399) |
Cash Flows from Investing Activities: | ||
Cash deposited into Trust Account | (210,000) | |
Cash withdrawn from Trust Account to pay franchise tax | 7,138 | |
Net cash (used in) provided by investing activities | (210,000) | 7,138 |
Cash Flows from Financing Activities: | ||
Proceeds from issuance of promissory note to Big Tree Cloud | 210,000 | |
Proceeds from issuance of promissory note to related party | 350,000 | |
Net cash provided by financing activities | 560,000 | |
Net change in cash | (394,399) | (236,261) |
Cash, beginning of the period | 425,852 | 293,569 |
Cash, end of the period | 31,453 | 57,308 |
Supplemental Disclosure of Non-cash Investing and Financing Activities | ||
Accretion of Common stock to redemption value | $ 563,171 | $ 2,615,348 |
Description of Organization and
Description of Organization and Business Operations | 3 Months Ended |
Mar. 31, 2024 | |
Description of Organization and Business Operations [Abstarct] | |
Description of Organization and Business Operations | Note 1 — Description of Organization and Business Operations Plutonian Acquisition Corp. (the “Company” or “Plutonian”) is a newly organized blank check company incorporated as a Delaware corporation on March 11, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (“Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. As of March 31, 2024, the Company had not commenced any operations. All activities through March 31, 2024 are related to the Company’s formation and the initial public offering (“IPO” as defined below) and, subsequent to the IPO, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is Plutonian Investments LLC, a Delaware limited liability company which is controlled by Mr. Guojian Zhang (the “Sponsor”). The registration statement for the Company’s IPO became effective on November 9, 2022. On November 15, 2022, the Company consummated the IPO of 5,750,000 units (the “Public Units’), including the full exercise of the over-allotment option of 750,000 Units granted to the underwriters. The Public Units were sold at an offering price of $10.00 per unit generating gross proceeds of $57,500,000. Simultaneously with the IPO, the Company sold to its Sponsor 266,125 units at $10.00 per unit (the “Private Units”) in a private placement generating total gross proceeds of $2,661,250, which is described in Note 5. Each Unit consists of one share of common stock of the Company, par value $0.0001 per share (the “Shares”), one redeemable warrant entitling its holder to purchase one Share at a price of $11.50 per Share, and one right to receive one-sixth (1/6) of one share upon the consummation of the Company’s initial business combination. Transaction costs amounted to $3,676,399, consisted of $575,000 of underwriting fees, $2,012,500 of deferred underwriting fees (payable only upon completion of a Business Combination) and $1,088,899 of other offering costs. Upon the closing of the IPO and the private placement on November 15, 2022, a total of $58,506,250 was placed in a trust account (the “Trust Account”) maintained by Continental Stock Transfer & Trust Company as a trustee and will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”), and that invest only in direct U.S. government treasury obligations. These funds will not be released until the earlier of the completion of the initial Business Combination and the liquidation due to the Company’s failure to complete a Business Combination within the applicable period of time. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders. In addition, interest income earned on the funds in the Trust Account may be released to the Company to pay its income or other tax obligations. With these exceptions, expenses incurred by the Company may be paid prior to a business combination only from the net proceeds of the IPO and private placement not held in the Trust Account. Pursuant to Nasdaq listing rules, the Company’s initial Business Combination must occur with one or more target businesses having an aggregate fair market value equal to at least 80% of the value of the funds in the Trust account (excluding any deferred underwriting discounts and commissions and taxes payable on the income earned on the Trust Account), which the Company refers to as the 80% test, at the time of the execution of a definitive agreement for its initial Business Combination, although the Company may structure a Business Combination with one or more target businesses whose fair market value significantly exceeds 80% of the trust account balance. If the Company is no longer listed on Nasdaq, it will not be required to satisfy the 80% test. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.175 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income tax obligations). The Public Shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO in accordance with the Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares of common stock voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor and any of the Company’s officers or directors that may hold Insider Shares (as defined in Note 5) (the “Initial Stockholders”) and the underwriters have agreed (a) to vote their Insider Shares, Private Shares (as defined in Note 4), and any Public Shares purchased during or after the IPO in favor of approving a Business Combination and (b) not to convert any shares (including the Insider Shares) in connection with a stockholder vote to approve, or sell the shares to the Company in any tender offer in connection with, a proposed Business Combination. The Initial Stockholders have agreed (a) to waive their redemption rights with respect to the Insider Shares, Private Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose, or vote in favor of, an amendment to the Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. Initially, the Company had nine months (or up to 18 months) from the closing of the IPO to consummate a Business Combination (the “Combination Period”). If the Company anticipates that it may not be able to consummate its initial Business Combination within nine months, it may, by resolution of the board if requested by the Sponsor, extend the period of time to consummate a Business Combination up to nine times, each by an additional one month (for a total of up to 18 months to complete a Business Combination), subject to the Sponsor depositing additional funds into the Trust Account in the amount of $189,750 (or $0.033 per public share per month), up to an aggregate of $1,707,750 or $0.297 per public share (for an aggregate of nine months), on or prior to the date of the applicable deadline, for each extension. On August 8, 2023, the Company held a special meeting of stockholders, at which the Company’s stockholders approved (i) an amendment to the Company’s amended and restated certificate of incorporation (the “Extension Amendment”) and (ii) an amendment (the “Trust Amendment”) to the Investment Management Trust Agreement, dated November 9, 2022, by and between the Company and Continental Stock Transfer & Trust Company to allow the Company to extend the date by which the Company must consummate a business combination, up to four times for an additional three months each time, from August 15, 2023 to August 15, 2024 (the date that is 21 months from the closing date of the Company’s initial public offering of units). In connection with the stockholders’ vote at the special meeting, an aggregate of 2,510,358 shares with redemption value of approximately $26,244,894 (or $10.45 per share) of the Company’s common stock were tendered for redemption. On August 1, 2023, $210,000 was deposited into the Trust Account to extend the business combination period from August 15, 2023 to November 15, 2023. On August 8, 2023, the Company issued a promissory note of $210,000 to the Sponsor for the extension payment. The promissory note is unsecured, interest-free and payable on the earlier of: 1) the date on which the Company consummates an initial business combination, or 2) the date the Company liquidates if a business combination is not consummated. The Sponsor may elect to convert the promissory note into 25,200 shares ($8.33 per share) of the Company common stock. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes payable, and less certain amount of interest to pay dissolution expenses) divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Initial Stockholders have agreed to waive their liquidation rights with respect to the Insider Shares and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the IPO, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than $10.175. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (excluding the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.175 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.175 per share due to reductions in the value of the trust assets, in each case less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. On October 9, 2023, Plutonian entered into an Agreement and Plan of Merger (as amended from time to time, the “Agreement”) with (i) Big Tree Cloud International Group Limited, a Cayman Islands exempted company (“Holdco”), (ii) Big Tree Cloud Holdings Limited, an exempted company incorporated in Cayman Islands and a direct wholly-owned subsidiary of Holdco (“PubCo”), (iii) Big Tree Cloud Merger Sub I Limited, an exempted company incorporated in Cayman Islands and a direct wholly-owned subsidiary of PubCo (“Merger Sub 1”), (iv) Big Tree Cloud Merger Sub II Inc., a Delaware corporation and a direct wholly-owned subsidiary of PubCo (“Merger Sub 2” and, together with PubCo and Merger Sub 1, each an “Acquisition Entity” and collectively, the “Acquisition Entities”), and (v) Guangdong Dashuyun Investment Holding Group Co., Ltd. ( 广东省大树云投资控股集团有限公司 Pursuant to the Agreement and subject to the terms and conditions set forth therein, (i) Merger Sub 1 will merge with and into the Holdco (the “Initial Merger”) whereby the separate existence of Merger Sub 1 will cease and Holdco will be the surviving corporation of the Initial Merger and become a wholly owned subsidiary of PubCo, and (ii) following the Initial Merger Effective Time, Merger Sub 2 will merge with and into SPAC (the “SPAC Merger”, and together with the Initial Merger, the “Mergers”), the separate existence of Merger Sub 2 will cease and SPAC will be the surviving corporation of the SPAC Merger and a direct wholly owned subsidiary of PubCo. The Mergers imply a current equity value of the Company at $500 million prior to the closing of the Mergers (the “Closing”). As a result of the Mergers, among other things, (i) each outstanding share in Holdco shall automatically be cancelled, and in exchange for the right to receive newly issued ordinary shares in PubCo (“PubCo Ordinary Shares”) at the Holdco Exchange Ratio; (ii) each outstanding Plutonian Unit will be automatically detached; (iii) each unredeemed outstanding share of Plutonian Common Stock will be cancelled in exchange for the right to receive one PubCo Ordinary Share, (iv) each outstanding Plutonian Rights will be cancelled and cease to exist in exchange for the right to receive one-sixth (1/6) PubCo Ordinary Share, and (v) each outstanding Plutonian Warrant will be cancelled in exchange for the right to receive one PubCo Warrant. Each outstanding PubCo Ordinary Share will have a value at the time of the Closing of $10.00. In addition, following the Closing, PubCo will issue an aggregate of up to 20,000,000 PubCo Ordinary Shares (the “Earnout Shares”) to the Holdco’s shareholders who hold Holdco’s shares as of immediately prior to the Initial Merger Effective Time on a pro rata basis upon the occurrence of the Earn-out Event. Earn-out Event is defined as the event where the Company Group first reports that there has been, in aggregate, no less than 200 department stores, grocery stores, pharmacies, supermarkets and other retail stores or vendors, each with a gross floor area of no less than 500 square meters, engaged in selling Dashuyun Group’s personal care products or other consumer goods. Concurrently with the execution of the Agreement, Sponsor has entered into and delivered a support agreement with the Holdco, the Company, each of the Acquisition Entities and Plutonian, pursuant to which the Sponsor has agreed, among others, to vote in favor of the Agreement and the transactions contemplated thereunder at the SPAC Special Meeting in accordance with the Insider Letter. As part of the Agreement, on November 9, 2023, January 31, 2024 and May 15, 2024, Big Tree Cloud International Group Limited (“Big Tree Cloud”) provided a loan of $210,000 per loan to the Company which was deposited into the Trust Account to extend the Company’s initial business combination period from November 15, 2023 to August 15, 2024. On November 9, 2023, January 31, 2024 and May 15, 2024, the Company issued three promissory notes of $210,000 per note to Big Tree Cloud for the extension payments. The promissory note is unsecured, interest-free and payable on the earliest of 1) the date on which the Company consummates an initial business combination, 2) the date on which the Agreement is terminated in accordance with its terms, or 3) August 15, 2024. Big Tree Cloud may elect to convert the promissory note into 25,200 shares ($8.33 per share) of the Company common stock. Going Concern Consideration As of March 31, 2024, the Company had cash of $31,453 and a working capital deficit of $2,562,483. The Company’s liquidity needs prior to the consummation of the IPO had been satisfied through a payment from the Sponsor of $25,000 for the Insider Shares and the loan under an unsecured promissory note from the Sponsor of $200,000. On June 20, 2023, August 8, 2023, September 14, 2023, December 27, 2023, and March 19, 2024, the Sponsor provided a loan of $150,000, $210,000, $140,000, $300,000, and $350,000, respectively, to be used, in part, for working capital and transaction costs (including extension fees) related to the Business Combination (see Note 5). The Company has until August 15, 2024 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution. The Company expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination. The Company may need to obtain additional financing either to complete its Business Combination or because it becomes obligated to redeem a significant number of public shares upon consummation of its Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, the Company would only complete such financing simultaneously with the completion of our Business Combination. If the Company is unable to complete its Business Combination because it does not have sufficient funds available, it will be forced to cease operations and liquidate the Trust Account. In addition, following the Business Combination, if cash on hand is insufficient, the Company may need to obtain additional financing in order to meet its obligations. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to complete a Business Combination by August 15, 2024 (unless the Company extends the time to complete a Business Combination), then the Company will cease all operations except for the purpose of liquidating. The liquidity condition and the date for liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements. The financial statement does not include any adjustments that might result from the outcome of this uncertainty. Risks and Uncertainties In February 2022, an armed conflict escalated between Russia and Ukraine. The sanctions announced by the United States and other countries against Russia and Belarus following Russia’s invasion of Ukraine to date include restrictions on selling or importing goods, services, or technology in or from affected regions and travel bans and asset freezes impacting connected individuals and political, military, business, and financial organizations in Russia and Belarus. The United States and other countries could impose wider sanctions and take other actions should the conflict further escalate. Separately, in October 2023, Israel and certain Iranian-backed Palestinian forces began an armed conflict in Israel, the Gaza Strip, and surrounding areas, which threatens to spread to other Middle Eastern countries including Lebanon and Iran. As a result of the ongoing Russia/Ukraine, Hamas/Israel conflicts and/or other future global conflicts, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and potential future sanctions on the world economy and the specific impact on the Company’s financial position, results of operations or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Use of Funds Restricted for Payment of Taxes In August 2023, the Company withdrew approximately $434,450 of interest income earned in the Trust Account which was used to pay $370,000 income tax on January 11, 2024. Such amount was restricted for payment of the Company’s income and franchise tax liabilities as provided in the Company’s charter. During the first quarter of 2024, approximately $7,631 of these funds were inadvertently used for the payments of general operating expenses. These funds were replenished to the Company’s operating account by the Sponsor loan on March 20, 2024. Inflation Reduction Act of 2022 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. As a result of the redemptions by the public stockholders in August 2023, the Company recorded $262,449 excise tax liability as of March 31, 2024. The Company will continue to monitor for updates to the Company’s business along with guidance issued with respect to the IR Act to determine whether any adjustments are needed to the Company’s tax provision in future periods. |
Significant Accounting Policies
Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2024 | |
Significant Accounting Policies [Abstract] | |
Significant Accounting Policies | Note 2 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The interim results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected through December 31, 2024 or for any future periods. These financial statements should be read in conjunction with the Company’s 2023 Annual Report on Form 10-K as filed with the SEC on April 12, 2024. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates In preparing these unaudited financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $31,453 and $425,852 in cash and none in cash equivalents as of March 31, 2024 and December 31, 2023, respectively. Investments Held in Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of investments in money market funds that invest in U.S. government securities. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust Account is determined using available market information. Offering Costs The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, “Other Assets and Deferred Costs – SEC Materials” (“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Offering costs were $3,676,399 consisting principally of underwriting, legal, accounting and other expenses that are directly related to the IPO and charged to stockholders’ equity upon the completion of the IPO on November 15, 2022. Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The Company’s effective tax rate was (31.38%) and 30.20% for the three months ended March 31, 2024 and 2023, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three months ended March 31, 2024 and 2023, due to the change of valuation allowance on the deferred tax assets and non-deductible M&A expenses. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. While ASC 740 identifies usage of an effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant, unusual or infrequent. Computing the effective tax rate for the Company is complicated due to the potential impact of the timing of any Business Combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expense in a current period based on ASC 740-270-25-3 which states, “If an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (benefit) but is otherwise able to make a reasonable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the usual elements that can impact its annualized book income and its impact on the effective tax rate. As such, the Company is computing its taxable income (loss) and associated income tax provision based on actual results through March 31, 2024. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) Per Share The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of March 31, 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. The net income (loss) per share presented in the statements of operations is based on the following: Three Months Ended 2024 2023 Net income (loss) $ (393,098 ) $ 296,953 Accretion of common stock to redemption value (1) (563,171 ) (2,615,348 ) Net loss including accretion of common stock to redemption value $ (956,269 ) $ (2,318,395 ) Three Months Ended Three Months Ended Redeemable Non- Redeemable Non- Basic and diluted net income (loss) per common stock Numerator: Allocation of net loss $ (619,499 ) $ (336,770 ) $ (1,774,805 ) $ (543,592 ) Accretion of common stock to redemption value 563,171 — 2,615,348 — Allocation of net income (loss) $ (56,328 ) $ (336,770 ) $ 840,543 $ (543,592 ) Denominator: Basic and diluted weighted average shares outstanding 3,239,642 1,761,125 5,750,000 1,761,125 Basic and diluted net income (loss) per common stock $ (0.02 ) $ (0.19 ) $ 0.15 $ (0.31 ) (1) Accretion amount includes extension fees deposited into the Trust Account and franchise and income taxes to be paid out of the Trust Account. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company is not exposed to significant risks on such account as of March 31, 2024 and December 31, 2023. As of March 31, 2024 and December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments FASB ASC Topic 820 “Fair Value Measurements and Disclosures” defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. FASB ASC Topic 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels based on the inputs as follows: Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the consolidated balance sheet. The fair values of cash and cash equivalents, and other current assets, accrued expenses, due to sponsor are estimated to approximate the carrying values as of March 31, 2024 and December 31, 2023 due to the short maturities of such instruments. See Note 8 for the disclosure of the Company’s assets and liabilities that were measured at fair value on a recurring basis. Warrants The Company accounts for warrants (Public Warrants or Private Warrants) as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company has made a policy election in accordance with ASC 480-10-S99-3A and recognizes changes in redemption value in additional paid-in capital (or accumulated deficit in the absence of additional paid-in capital) over an expected 9-month period leading up to a Business Combination. For the three months ended March 31, 2024, the Company recorded $563,171 total accretion of common stock to redemption value. At March 31, 2024, the amount of common stock subject to possible redemption reflected in the balance sheet are reconciled in the following table: Gross proceeds $ 57,500,000 Less: Proceeds allocated to public warrants (632,500 ) Proceeds allocated to public rights (1,322,500 ) Allocation of offering costs related to redeemable shares (3,551,402 ) Plus: Accretion of carrying value to redemption value 1,570,929 Common stock subject to possible redemption - December 31, 2022 53,564,527 Plus: Accretion of carrying value to redemption value 7,471,063 Redemption of public stockholders (26,244,894 ) Common stock subject to possible redemption- December 31, 2023 34,790,696 Plus: Accretion of carrying value to redemption value – three months ended March 31, 2024 563,171 Common stock subject to possible redemption- March 31, 2024 $ 35,353,867 Recent Accounting Pronouncements In December 2023, the FASB issued Accounting Standards Update 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosure” (“ASU 2023-09”). ASU 2023-09 mostly requires, on an annual basis, disclosure of specific categories in an entity’s effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. The incremental disclosures may be presented on a prospective or retrospective basis. The ASU is effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2023-09 would have on its financial position, results of operations or cash flows. Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
Initial Public Offering
Initial Public Offering | 3 Months Ended |
Mar. 31, 2024 | |
Initial Public Offering [Abstract] | |
Initial Public Offering | Note 3 — Initial Public Offering On November 15, 2022, the Company sold 5,750,000 Units at a price of $10.00 per Units (including the full exercise of the over-allotment option of 750,000 Units granted to the underwriters), generating gross proceeds of $57,500,000. Each Unit consists of one share of common stock, one right (“Public Right”), and one redeemable warrant (“Public Warrant”). Each Public Right will convert into one-sixth (1/6) of a share of common stock upon the consummation of an initial Business Combination. Each Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment, and each six rights entitle the holder thereof to receive one share of common stock at the closing of an initial Business Combination. The Company will not issue fractional shares. As a result, Public Rights may only be converted in multiples of six. The Warrants will become exercisable on the later of the 30 days after completion of the Company’s initial Business Combination or 12 months from the closing of the IPO, and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation. |
Private Placement
Private Placement | 3 Months Ended |
Mar. 31, 2024 | |
Private Placement [Abstract] | |
Private Placement | Note 4 — Private Placement Simultaneously with the closing of the IPO, The Sponsor purchased an aggregate of 266,125 Private Units at a price of $10.00 per Private Unit for an aggregate purchase price of $2,661,250 in a private placement. The Private Units are identical to the Public Units except with respect to certain registration rights and transfer restrictions. The Private Warrants will be identical to the Public Warrants, except that the Private Warrants will be entitled to registration rights, and the Private Warrants (including the common shares issuable upon the exercise of the Private Warrants) will not be transferable, assignable or salable until after the completion of a Business Combination, except to permitted transferees. The proceeds from the Private Units were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within nine months (or up to 18 months if the time to complete a business combination is extended) from the closing of the IPO, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Units and all underlying securities will expire worthless. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2024 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 5 — Related Party Transactions Insider Shares On February 20, 2022, the Company issued 1,437,500 shares of common stock to the Initial Stockholders (the “Insider Shares”) for an aggregated consideration of $25,000, or approximately $0.017 per share. The Initial Stockholders have agreed to forfeit up to 187,500 Insider Shares to the extent that the over-allotment option is not exercised in full so that the Initial Stockholders collectively own 20% of the Company’s issued and outstanding shares after the IPO (assuming the Initial Stockholders do not purchase any Public Shares in the IPO and excluding the Private Units). As a result of the underwriters’ full exercise of the over-allotment option on November 15, 2022, no Insider Share were forfeited. As of March 31, 2024, 1,437,500 Insider Shares were issued and outstanding. The Initial Stockholders have agreed not to transfer, assign or sell any of their Insider Shares (except to certain permitted transferees) until the earlier of (1) 150 calendar days after the date of the consummation of the Company’s initial Business Combination and the date on which the closing price of the Company’s shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the Company’s initial Business Combination or (2) six months after the date of the consummation of the Company’s initial Business Combination, or earlier, in either case, if, subsequent to the Company’s initial Business Combination, the Company consummates a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Promissory Note — Related Party On February 20, 2022, the Sponsor agreed to loan the Company up to an aggregate amount of $200,000 to be used, in part, for transaction costs incurred in connection with the IPO (the “Promissory Note”). The Promissory Note is unsecured, interest-free and due on the closing of the IPO. The Company repaid the outstanding balance of $200,000 to the Sponsor on November 29, 2022. On June 20, 2023, August 8, 2023, September 14, 2023, December 27, 2023, and March 19, 2024, the Sponsor provided the Company with a loan of $150,000 (“Promissory Note 1”), $210,000 (“Promissory Note 2”), $140,000 (“Promissory Note 3”), $300,000 (“Promissory Note 4”), and $350,000 (“Promissory Note 5), respectively, to be used, in part, for working capital and term extension fees. Promissory Note 1 and Promissory Note 3 are unsecured, interest-free and payable on the earlier of: 1) the date on which the Company consummates an initial business combination, or 2) the date the Company liquidates if a business combination is not consummated. The Sponsor may elect to convert the promissory notes in shares of the Company common stock at a fixed price of $10.00 per share at any time when promissory notes remain outstanding. Promissory Note 2, 4 and 5 have the same terms as Promissory Note 1 and 3, except the Sponsor may elect to convert the promissory note into 25,200 shares, 36,000 shares and 42,000 shares ($8.33 per share) of the Company common stock. As of March 31, 2024 and December 31, 2023, $1,150,000 and $800,000 were outstanding, respectively, under all the promissory notes. Related Party Loans In addition, in order to finance transaction costs in connection with searching for a target business or consummating an intended initial Business Combination, the initial stockholders, officers, directors or their affiliates may, but are not obligated to, loan us funds as may be required. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from the Trust Account would be used for such repayment. Such loans would be evidenced by promissory notes. The notes would either be paid upon consummation of the Company’s initial Business Combination, without interest, or, at the lender’s discretion, up to $600,000 of the notes may be converted upon consummation of the Company’s Business Combination into Private Units at a price of $10.00 per unit. As of March 31, 2024 and December 31, 2023, the Company had no borrowings under the related party loans. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2024 | |
Commitments and Contingencies [Abstract] | |
Commitments and Contingencies | Note 6 — Commitments and Contingencies Registration Rights The holders of the Company’s Insider Shares issued and outstanding as well as the holders of the Private Units and any Private Units the Company’s insiders, officers, directors, or their affiliates may be issued in payment of working capital loans and extension loans made to the Company (and the securities underlying the Private Units) will be entitled to registration rights pursuant to an agreement. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Insider Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from certain transfer restrictions. The holders of a majority of the Private Units (including the Private Units issued in payment of working capital loans and extension loans made to the Company) can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company has granted EF Hutton, division of Benchmark Investments, LLC, the representative of the underwriters a 45-day option from the date of this offering to purchase up to 750,000 additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. On November 15, 2022, the underwriters fully exercised the over-allotment option to purchase 750,000 units, generating gross proceeds to the Company of $7,500,000 (see Note 3). The underwriters were paid a cash underwriting discount of 1.0% of the gross proceeds of the IPO, or $575,000. In addition, the underwriters are entitled to a deferred underwriting fee of 3.5% of the gross proceeds of the IPO, or $2,012,500, which will be paid upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement. Additionally, the Company has committed to issue the underwriters and/or its designees 57,500 shares of common stock or the representative shares, at the closing of the IPO as part of representative compensation. As of November 15, 2022, 57,500 representative shares were issued. Financial Advisors Agreement On November 10, 2023, the Company entered into a FA Engagement Letter with South Pacific Gyre Investment Limited (“South Pacific”), pursuant to which the latter agreed to provide certain capital markets advisory services to Company in connection with the Business Combination in consideration for advisory fees. South Pacific has agreed to be paid entirely in PubCo Ordinary Shares, in an amount of 2,000,000 PubCo Ordinary Shares which equal to 4% of the equity value of Big Tree Cloud, provided that all the PubCo Ordinary Shares issuable to South Pacific shall be subject to a lock-up arrangement for a period of at least six months. Deferred Legal Fees The Company engaged a legal counsel firm for legal advisory services, and the legal counsel agreed to defer $450,000 of their fees. The deferred fee is payable in the event that the Company completes a Business Combination or when the Business Combination is aborted. As of March 31, 2024 and December 31, 2023, the Company accrued $450,000 and $0 deferred legal fees, respectively. |
Stockholders_ Deficit
Stockholders’ Deficit | 3 Months Ended |
Mar. 31, 2024 | |
Stockholders’ Deficit [Abstract] | |
Stockholders’ Deficit | Note 7 — Stockholders’ Deficit Common Stock Rights The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the Delaware General Corporation Law. As a result, a holder must hold rights in multiples of six in order to receive shares for all of its rights upon closing of a Business Combination. If the Company is unable to complete an initial Business Combination within the required time period and it liquidates the funds held in the Trust Account, holders of warrants and rights will not receive any of such funds with respect to their warrants and rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants and rights, and the warrants and rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of an initial Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, holders of the rights might not receive the shares of common stock underlying the rights. As of March 31, 2024 and December 31, 2023, there were 6,016,125 rights issued and outstanding. Warrants In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the board of directors) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Price”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Price and the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Company may redeem the outstanding warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the 30-day redemption period; ● if, and only if, the last reported sale price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the to the warrant holders. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. In such event, each holder would pay the exercise price by surrendering the warrants in exchange for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the excess of the “fair market value” (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. Except as described above, no warrants will be exercisable and the Company will not be obligated to issue common stock unless at the time a holder seeks to exercise such warrant, a prospectus relating to the common stock issuable upon exercise of the warrants is current and the common stock has been registered or qualified or deemed to be exempt under the securities laws of the state of residence of the holder of the warrants. Under the terms of the warrant agreement, the Company has agreed to use its best efforts to meet these conditions and to maintain a current prospectus relating to the common stock issuable upon exercise of the warrants until the expiration of the warrants. However, the Company cannot assure that it will be able to do so and, if the Company does not maintain a current prospectus relating to the common stock issuable upon exercise of the warrants, holders will be unable to exercise their warrants and the Company will not be required to settle any such warrant exercise. If the prospectus relating to the common stock issuable upon the exercise of the warrants is not current or if the common stock is not qualified or exempt from qualification in the jurisdictions in which the holders of the warrants reside, the Company will not be required to net cash settle or cash settle the warrant exercise, the warrants may have no value, the market for the warrants may be limited and the warrants may expire worthless. The Private Warrants will be identical to the Public Warrants, except that the Private Warrants will be entitled to registration rights, and the Private Warrants (including the common shares issuable upon the exercise of the Private Warrants) will not be transferable, assignable or salable until after the completion of a Business Combination, except to permitted transferees. As of March 31, 2024 and December 31, 2023, there were 6,016,125 warrants issued and outstanding. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2024 | |
Fair Value Measurements [Abstract] | |
Fair Value Measurements | Note 8 — Fair Value Measurements The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. March 31, Quoted Significant Significant Assets Marketable securities held in Trust Account $ 35,627,550 $ 35,627,550 $ — $ — December 31, Quoted Significant Significant Assets Marketable securities held in Trust Account $ 34,959,697 $ 34,959,697 $ — $ — |
Promissory Notes to Big Tree Cl
Promissory Notes to Big Tree Cloud | 3 Months Ended |
Mar. 31, 2024 | |
Promissory Notes to Big Tree Cloud [Abstract] | |
Promissory Notes to Big Tree Cloud | Note 9 — Promissory Notes to Big Tree Cloud Pursuant to the Merger Agreement, on November 9, 2023 and January 31, 2024, Big Tree Cloud provided a loan of $210,000 each time to the Company which was deposited into the Trust Account to extend the Company’s initial business combination period from November 15, 2023 to May 15, 2024. The Company issued two promissory notes of $210,000 each to Big Tree Cloud in exchange for the extension payment. The promissory notes are unsecured, interest-free and payable on the earliest of: 1) the date on which the Company consummates an initial business combination, 2) the date on which the Agreement is terminated in accordance with its terms, or 3) August 15, 2024. Big Tree Cloud may elect to convert the promissory note into 25,200 shares ($8.33 per share) of the Company common stock. |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2024 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on this review, as further disclosed in the footnotes and except as disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On April 30, 2024, the Company held a special meeting of stockholders (the “Special Meeting”). At the Special Meeting, 3,428,535 shares of common stock of Plutonian or 68.6% of the shares entitled to vote at the Special Meeting were represented in person or by proxy. Stockholders approved (1) the Business Combination Proposal, a proposal to In connection with the stockholders’ vote at the Special Meeting, a total of 3,172,908 shares of common stock of Plutonian were tendered for redemption. As a result, approximately $34.7 million (approximately $10.95 per share) will be removed from the Company’s Trust Account to pay such holders, without taking into account additional allocation of payments to cover any tax obligation of the Company, such as franchise taxes, but not including any excise tax, since that date. Following redemptions, the Company will have 1,827,859 shares of Common Stock outstanding. On May 15, 2024, Big Tree Cloud provided a loan of $210,000 to the Company which was deposited into the Trust Account to extend the Company’s initial business combination period from May 15, 2024 to August 15, 2024. The Company issued a promissory note of $210,000 to Big Tree Cloud in exchange for the extension payment. The promissory note is unsecured, interest-free and payable on the earliest of: 1) the date on which the Company consummates an initial business combination, 2) the date on which the Agreement is terminated in accordance with its terms, or 3) August 15, 2024. Big Tree Cloud may elect to convert the promissory note into 25,200 shares ($8.33 per share) of the Company common stock. On May 15, 2024, the Company deposited $210,000 into the Trust Account to extend the Company’s initial business combination period from May 15, 2024 to August 15, 2024. Accordingly, the Company now has until August 15, 2024 to complete its initial business combination. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Pay vs Performance Disclosure | ||
Net Income (Loss) | $ (393,098) | $ 296,953 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Mar. 31, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 3 Months Ended |
Mar. 31, 2024 | |
Significant Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The interim results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected through December 31, 2024 or for any future periods. These financial statements should be read in conjunction with the Company’s 2023 Annual Report on Form 10-K as filed with the SEC on April 12, 2024. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates In preparing these unaudited financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $31,453 and $425,852 in cash and none in cash equivalents as of March 31, 2024 and December 31, 2023, respectively. |
Investments Held in Trust Account | Investments Held in Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of investments in money market funds that invest in U.S. government securities. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust Account is determined using available market information. |
Offering Costs | Offering Costs The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, “Other Assets and Deferred Costs – SEC Materials” (“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Offering costs were $3,676,399 consisting principally of underwriting, legal, accounting and other expenses that are directly related to the IPO and charged to stockholders’ equity upon the completion of the IPO on November 15, 2022. |
Income Taxes | Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The Company’s effective tax rate was (31.38%) and 30.20% for the three months ended March 31, 2024 and 2023, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three months ended March 31, 2024 and 2023, due to the change of valuation allowance on the deferred tax assets and non-deductible M&A expenses. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. While ASC 740 identifies usage of an effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant, unusual or infrequent. Computing the effective tax rate for the Company is complicated due to the potential impact of the timing of any Business Combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expense in a current period based on ASC 740-270-25-3 which states, “If an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (benefit) but is otherwise able to make a reasonable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the usual elements that can impact its annualized book income and its impact on the effective tax rate. As such, the Company is computing its taxable income (loss) and associated income tax provision based on actual results through March 31, 2024. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. |
Net Income (Loss) Per Share | Net Income (Loss) Per Share The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of March 31, 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. The net income (loss) per share presented in the statements of operations is based on the following: Three Months Ended 2024 2023 Net income (loss) $ (393,098 ) $ 296,953 Accretion of common stock to redemption value (1) (563,171 ) (2,615,348 ) Net loss including accretion of common stock to redemption value $ (956,269 ) $ (2,318,395 ) Three Months Ended Three Months Ended Redeemable Non- Redeemable Non- Basic and diluted net income (loss) per common stock Numerator: Allocation of net loss $ (619,499 ) $ (336,770 ) $ (1,774,805 ) $ (543,592 ) Accretion of common stock to redemption value 563,171 — 2,615,348 — Allocation of net income (loss) $ (56,328 ) $ (336,770 ) $ 840,543 $ (543,592 ) Denominator: Basic and diluted weighted average shares outstanding 3,239,642 1,761,125 5,750,000 1,761,125 Basic and diluted net income (loss) per common stock $ (0.02 ) $ (0.19 ) $ 0.15 $ (0.31 ) (1) Accretion amount includes extension fees deposited into the Trust Account and franchise and income taxes to be paid out of the Trust Account. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company is not exposed to significant risks on such account as of March 31, 2024 and December 31, 2023. As of March 31, 2024 and December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments FASB ASC Topic 820 “Fair Value Measurements and Disclosures” defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. FASB ASC Topic 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels based on the inputs as follows: Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the consolidated balance sheet. The fair values of cash and cash equivalents, and other current assets, accrued expenses, due to sponsor are estimated to approximate the carrying values as of March 31, 2024 and December 31, 2023 due to the short maturities of such instruments. See Note 8 for the disclosure of the Company’s assets and liabilities that were measured at fair value on a recurring basis. |
Warrants | Warrants The Company accounts for warrants (Public Warrants or Private Warrants) as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. |
Common Stock Subject to Possible Redemption | Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company has made a policy election in accordance with ASC 480-10-S99-3A and recognizes changes in redemption value in additional paid-in capital (or accumulated deficit in the absence of additional paid-in capital) over an expected 9-month period leading up to a Business Combination. For the three months ended March 31, 2024, the Company recorded $563,171 total accretion of common stock to redemption value. At March 31, 2024, the amount of common stock subject to possible redemption reflected in the balance sheet are reconciled in the following table: Gross proceeds $ 57,500,000 Less: Proceeds allocated to public warrants (632,500 ) Proceeds allocated to public rights (1,322,500 ) Allocation of offering costs related to redeemable shares (3,551,402 ) Plus: Accretion of carrying value to redemption value 1,570,929 Common stock subject to possible redemption - December 31, 2022 53,564,527 Plus: Accretion of carrying value to redemption value 7,471,063 Redemption of public stockholders (26,244,894 ) Common stock subject to possible redemption- December 31, 2023 34,790,696 Plus: Accretion of carrying value to redemption value – three months ended March 31, 2024 563,171 Common stock subject to possible redemption- March 31, 2024 $ 35,353,867 |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In December 2023, the FASB issued Accounting Standards Update 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosure” (“ASU 2023-09”). ASU 2023-09 mostly requires, on an annual basis, disclosure of specific categories in an entity’s effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. The incremental disclosures may be presented on a prospective or retrospective basis. The ASU is effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2023-09 would have on its financial position, results of operations or cash flows. Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
Significant Accounting Polici_2
Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Significant Accounting Policies [Abstract] | |
Schedule of Net Income (Loss) Per Share | The net income (loss) per share presented in the statements of operations is based on the following: Three Months Ended 2024 2023 Net income (loss) $ (393,098 ) $ 296,953 Accretion of common stock to redemption value (1) (563,171 ) (2,615,348 ) Net loss including accretion of common stock to redemption value $ (956,269 ) $ (2,318,395 ) Three Months Ended Three Months Ended Redeemable Non- Redeemable Non- Basic and diluted net income (loss) per common stock Numerator: Allocation of net loss $ (619,499 ) $ (336,770 ) $ (1,774,805 ) $ (543,592 ) Accretion of common stock to redemption value 563,171 — 2,615,348 — Allocation of net income (loss) $ (56,328 ) $ (336,770 ) $ 840,543 $ (543,592 ) Denominator: Basic and diluted weighted average shares outstanding 3,239,642 1,761,125 5,750,000 1,761,125 Basic and diluted net income (loss) per common stock $ (0.02 ) $ (0.19 ) $ 0.15 $ (0.31 ) (1) Accretion amount includes extension fees deposited into the Trust Account and franchise and income taxes to be paid out of the Trust Account. |
Schedule of Common Stock Subject to Possible Redemption | At March 31, 2024, the amount of common stock subject to possible redemption reflected in the balance sheet are reconciled in the following table: Gross proceeds $ 57,500,000 Less: Proceeds allocated to public warrants (632,500 ) Proceeds allocated to public rights (1,322,500 ) Allocation of offering costs related to redeemable shares (3,551,402 ) Plus: Accretion of carrying value to redemption value 1,570,929 Common stock subject to possible redemption - December 31, 2022 53,564,527 Plus: Accretion of carrying value to redemption value 7,471,063 Redemption of public stockholders (26,244,894 ) Common stock subject to possible redemption- December 31, 2023 34,790,696 Plus: Accretion of carrying value to redemption value – three months ended March 31, 2024 563,171 Common stock subject to possible redemption- March 31, 2024 $ 35,353,867 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Fair Value Measurements [Abstract] | |
Schedule of Fair Value on a Recurring Basis | The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. March 31, Quoted Significant Significant Assets Marketable securities held in Trust Account $ 35,627,550 $ 35,627,550 $ — $ — December 31, Quoted Significant Significant Assets Marketable securities held in Trust Account $ 34,959,697 $ 34,959,697 $ — $ — |
Description of Organization a_2
Description of Organization and Business Operations (Details) | 3 Months Ended | |||||||||||||||
Mar. 19, 2024 USD ($) | Dec. 27, 2023 USD ($) | Sep. 14, 2023 USD ($) shares | Aug. 31, 2023 USD ($) | Aug. 08, 2023 USD ($) shares | Jun. 20, 2023 USD ($) shares | Nov. 15, 2022 USD ($) $ / shares shares | Aug. 16, 2022 | Mar. 31, 2024 USD ($) $ / shares shares | Mar. 31, 2023 USD ($) | May 15, 2024 USD ($) | Jan. 31, 2024 USD ($) | Jan. 11, 2024 USD ($) | Dec. 31, 2023 USD ($) $ / shares | Nov. 09, 2023 USD ($) | Aug. 01, 2023 USD ($) | |
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Number of business entities | 1 | |||||||||||||||
Price per public share (in Dollars per share) | $ / shares | $ 10.175 | |||||||||||||||
Generating gross proceeds | $ 7,500,000 | |||||||||||||||
Common stock par value (in Dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | ||||||||||||||
Transaction costs | $ 3,676,399 | |||||||||||||||
Underwriting fees | 575,000 | |||||||||||||||
Deferred underwriting fees payable | 2,012,500 | $ 2,012,500 | ||||||||||||||
Offering costs | $ 1,088,899 | |||||||||||||||
Investment securities maturity term | 185 years | |||||||||||||||
Market value percentage | 80% | |||||||||||||||
Initial business combination percentage | 80% | |||||||||||||||
Trust account exceed percentage | 80% | |||||||||||||||
Percentage of test result | 80% | |||||||||||||||
Voting percentage | 50% | |||||||||||||||
Net tangible assets | $ 5,000,001 | |||||||||||||||
Obligation to redeem percentage | 100% | |||||||||||||||
Period of business combination | 18 years | |||||||||||||||
Shares redemption (in Shares) | shares | 2,510,358 | |||||||||||||||
Shares redemption value | $ 26,244,894 | |||||||||||||||
Redemption per share (in Dollars per share) | $ / shares | $ 10.45 | |||||||||||||||
Amount deposited into Trust Account to extend the business combination | $ 210,000 | |||||||||||||||
Conversion shares (in Shares) | shares | 42,000 | 36,000 | 25,200 | 25,200 | ||||||||||||
Per share of asset outstanding (in Dollars per share) | $ / shares | $ 10.175 | |||||||||||||||
Current equity value | $ 500,000,000 | |||||||||||||||
Aggregate ordinary shares (in Shares) | shares | 20,000,000 | |||||||||||||||
Loan amount | $ 210,000 | $ 210,000 | ||||||||||||||
Cash | $ 31,453 | |||||||||||||||
Working capital deficit | 2,562,483 | |||||||||||||||
Payment of related party debt | 350,000 | |||||||||||||||
Interest income earned | $ 434,450 | |||||||||||||||
Income tax payable | $ 370,000 | |||||||||||||||
General operating expenses | 7,631 | |||||||||||||||
Excise tax rate percentage | 1% | |||||||||||||||
Market value of share percentage | 1% | |||||||||||||||
Excise tax payable | $ 262,449 | $ 262,449 | ||||||||||||||
Promissory note [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Extension payment | $ 210,000 | $ 210,000 | $ 210,000 | |||||||||||||
Conversion price (in Dollars per share) | $ / shares | $ 8.33 | |||||||||||||||
Big Tree Cloud [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Conversion price (in Dollars per share) | $ / shares | $ 8.33 | |||||||||||||||
Unsecured Promissory Note [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Payment of related party debt | $ 200,000 | |||||||||||||||
Warrant [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Price per unit (in Dollars per share) | $ / shares | $ 11.5 | |||||||||||||||
PubCo [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Price per public share (in Dollars per share) | $ / shares | 10 | |||||||||||||||
Trust Account [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Price per public share (in Dollars per share) | $ / shares | $ 10.175 | |||||||||||||||
Trust account amount | $ 58,506,250 | |||||||||||||||
Deposit additional funds | $ 189,750 | |||||||||||||||
Sponsor [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Sale of units (in Shares) | shares | 266,125 | |||||||||||||||
Public share (in Dollars per share) | $ / shares | $ 0.033 | |||||||||||||||
Payment of related party debt | $ 25,000 | |||||||||||||||
Proceeds From Loans | $ 350,000 | $ 300,000 | $ 140,000 | $ 210,000 | $ 150,000 | |||||||||||
Sponsor [Member] | Promissory note [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Conversion shares (in Shares) | shares | 25,200 | |||||||||||||||
Subsequent Event [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Deposit additional funds | $ 210,000 | |||||||||||||||
Loan amount | 210,000 | |||||||||||||||
Subsequent Event [Member] | Promissory note [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Loan amount | $ 210,000 | |||||||||||||||
IPO [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Number of units issued (in Shares) | shares | 5,750,000 | |||||||||||||||
Price per public share (in Dollars per share) | $ / shares | $ 10 | |||||||||||||||
Generating gross proceeds | $ 57,500,000 | $ 57,500,000 | ||||||||||||||
Sale of units (in Shares) | shares | 5,750,000 | |||||||||||||||
Public share (in Dollars per share) | $ / shares | $ 10 | |||||||||||||||
Over-Allotment Option [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Number of units issued (in Shares) | shares | 750,000 | |||||||||||||||
Sale of units (in Shares) | shares | 750,000 | |||||||||||||||
Aggregate value | $ 1,707,750 | |||||||||||||||
Private Placement [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Public share (in Dollars per share) | $ / shares | $ 10 | |||||||||||||||
Gross proceeds | $ 2,661,250 | |||||||||||||||
Public Share [Member] | ||||||||||||||||
Description of Organization and Business Operations [Line Items] | ||||||||||||||||
Price per public share (in Dollars per share) | $ / shares | $ 10.175 | |||||||||||||||
Public share (in Dollars per share) | $ / shares | $ 0.297 |
Significant Accounting Polici_3
Significant Accounting Policies (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | Nov. 15, 2022 | |
Significant Accounting Policies [Abstract] | |||
Cash equivalents, at carrying value | $ 31,453 | $ 425,852 | |
Offering Costs | $ 3,676,399 | ||
Effective tax rate | (31.38%) | 30.20% | |
Statutory tax rate | 21% | 21% | |
Federal depository insurance coverage | $ 250,000 | ||
Accretion of Common stock to redemption value | $ 563,171 | $ 2,615,348 |
Significant Accounting Polici_4
Significant Accounting Policies (Details) - Schedule of Net Income (Loss) Per Share - USD ($) | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | ||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | |||
Net income (loss) | $ (393,098) | $ 296,953 | |
Accretion of common stock to redemption value | [1] | (563,171) | (2,615,348) |
Net loss including accretion of common stock to redemption value | (956,269) | (2,318,395) | |
Numerator: | |||
Accretion of common stock to redemption value | 563,171 | 2,615,348 | |
Redeemable Shares [Member] | |||
Numerator: | |||
Allocation of net loss | (619,499) | (1,774,805) | |
Accretion of common stock to redemption value | 563,171 | 2,615,348 | |
Allocation of net income (loss) | $ (56,328) | $ 840,543 | |
Denominator: | |||
Basic weighted average shares outstanding (in Shares) | 3,239,642 | 5,750,000 | |
Basic net income (loss) per common stock (in Dollars per share) | $ (0.02) | $ 0.15 | |
Non- Redeemable Shares [Member] | |||
Numerator: | |||
Allocation of net loss | $ (336,770) | $ (543,592) | |
Accretion of common stock to redemption value | |||
Allocation of net income (loss) | $ (336,770) | $ (543,592) | |
Denominator: | |||
Basic weighted average shares outstanding (in Shares) | 1,761,125 | 1,761,125 | |
Basic net income (loss) per common stock (in Dollars per share) | $ (0.19) | $ (0.31) | |
[1]Accretion amount includes extension fees deposited into the Trust Account and franchise and income taxes to be paid out of the Trust Account. |
Significant Accounting Polici_5
Significant Accounting Policies (Details) - Schedule of Net Income (Loss) Per Share (Parentheticals) - $ / shares | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Redeemable Shares [Member] | ||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||
Diluted weighted average shares outstanding | 3,239,642 | 5,750,000 |
Diluted net income (loss) per common stock | $ (0.02) | $ 0.15 |
Non- Redeemable Shares [Member] | ||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||
Diluted weighted average shares outstanding | 1,761,125 | 1,761,125 |
Diluted net income (loss) per common stock | $ (0.19) | $ (0.31) |
Significant Accounting Polici_6
Significant Accounting Policies (Details) - Schedule of Common Stock Subject to Possible Redemption - Common Stock Subject to Possible Redemption [Member] - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | |
Temporary Equity [Line Items] | |||
Gross proceeds | $ 57,500,000 | ||
Less: | |||
Proceeds allocated to public warrants | (632,500) | ||
Proceeds allocated to public rights | (1,322,500) | ||
Allocation of offering costs related to redeemable shares | (3,551,402) | ||
Plus: | |||
Accretion of carrying value to redemption value | $ 563,171 | $ 7,471,063 | 1,570,929 |
Redemption of public stockholders | (26,244,894) | ||
Common stock subject to possible redemption | $ 35,353,867 | $ 34,790,696 | $ 53,564,527 |
Initial Public Offering (Detail
Initial Public Offering (Details) - USD ($) | 3 Months Ended | |
Nov. 15, 2022 | Mar. 31, 2024 | |
IPO [Member] | ||
Initial Public Offering [Line items] | ||
Sale of units | 5,750,000 | |
Sale of Stock, Price Per Share | $ 10 | |
Generating gross proceeds | $ 57,500,000 | $ 57,500,000 |
IPO [Member] | Warrant [Member] | ||
Initial Public Offering [Line items] | ||
Common stock at a price | $ 11.5 | |
Over-Allotment Option [Member] | ||
Initial Public Offering [Line items] | ||
Sale of units | 750,000 |
Private Placement (Details)
Private Placement (Details) - Private Placement [Member] - Sponsor [Member] | 3 Months Ended |
Mar. 31, 2024 USD ($) $ / shares shares | |
Private Placement [Line Items] | |
Sponsor purchased an aggregate | shares | 266,125 |
Private units price per share | $ / shares | $ 10 |
Aggregate purchase price | $ | $ 2,661,250 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | 1 Months Ended | 3 Months Ended | |||||||
Sep. 14, 2023 | Aug. 08, 2023 | Jun. 20, 2023 | Nov. 29, 2022 | Feb. 20, 2022 | Mar. 31, 2024 | Mar. 19, 2024 | Dec. 31, 2023 | Dec. 27, 2023 | |
Related Party Transaction [Line Items] | |||||||||
Common stock per share (in Dollars per share) | $ 10.175 | ||||||||
Insider shares issued (in Shares) | 1,437,500 | ||||||||
Closing price of common stock equal or exceeds per share (in Dollars per share) | $ 12 | ||||||||
Aggregate loan amount | $ 200,000 | ||||||||
Repaid outstanding balance | $ 200,000 | ||||||||
Loans | $ 140,000 | $ 210,000 | $ 150,000 | $ 350,000 | $ 300,000 | ||||
Convert the promissory note shares (in Shares) | 42,000 | 36,000 | 25,200 | 25,200 | |||||
Outstanding amount | $ 1,150,000 | $ 800,000 | |||||||
Loan converted amount | $ 600,000 | ||||||||
Business Combination [Member] | |||||||||
Related Party Transaction [Line Items] | |||||||||
Business Combination price per share (in Dollars per share) | $ 10 | ||||||||
Initial Stockholders [Member] | |||||||||
Related Party Transaction [Line Items] | |||||||||
Issue of common stock share (in Shares) | 1,437,500 | ||||||||
Aggregated consideration | $ 25,000 | ||||||||
Common stock per share (in Dollars per share) | $ 0.017 | ||||||||
Shares subject to forfeiture (in Shares) | 187,500 | ||||||||
Percentage of issued and outstanding shares | 20% | ||||||||
Promissory note [Member] | |||||||||
Related Party Transaction [Line Items] | |||||||||
Conversion price per share (in Dollars per share) | 8.33 | ||||||||
Common Stock [Member] | Promissory note [Member] | |||||||||
Related Party Transaction [Line Items] | |||||||||
Conversion price per share (in Dollars per share) | $ 10 |
Commitments and Contingencies (
Commitments and Contingencies (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Nov. 15, 2022 | Mar. 31, 2024 | Dec. 31, 2023 | Nov. 10, 2023 | |
Commitments and Contingencies [Line Items] | ||||
Purchase of additional units (in Shares) | 1,437,500 | |||
Gross proceeds | $ 7,500,000 | |||
Underwriting discount percentage | 1% | |||
Percentage of deferred underwriting fee | 3.50% | |||
Ordinary shares (in Shares) | 1,761,125 | 1,761,125 | ||
Equity value percentage | 4% | |||
Fees | $ 450,000 | |||
Deferred legal fees | 450,000 | $ 0 | ||
Representative Shares [Member] | ||||
Commitments and Contingencies [Line Items] | ||||
Issuance of representative shares (in Shares) | 57,500 | |||
Underwriters [Member] | ||||
Commitments and Contingencies [Line Items] | ||||
Deferred underwriting fee payable | 2,012,500 | |||
PubCo [Member] | ||||
Commitments and Contingencies [Line Items] | ||||
Ordinary shares (in Shares) | 2,000,000 | |||
Over-Allotment Option [Member] | ||||
Commitments and Contingencies [Line Items] | ||||
Purchase of additional units (in Shares) | 750,000 | 750,000 | ||
IPO [Member] | ||||
Commitments and Contingencies [Line Items] | ||||
Gross proceeds | $ 57,500,000 | 57,500,000 | ||
Underwriting discount | $ 575,000 | |||
Issuance of representative shares (in Shares) | 57,500 |
Stockholders_ Deficit (Details)
Stockholders’ Deficit (Details) - $ / shares | 3 Months Ended | ||
Mar. 31, 2024 | Dec. 31, 2023 | Mar. 31, 2023 | |
Stockholders’ Deficit [Line Items] | |||
Common stock, shares authorized | 15,000,000 | 15,000,000 | |
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |
Common stock, vote | one | ||
Common stock, share outstanding | 1,761,125 | 1,761,125 | |
Shares subject to possible redemption | 3,239,642 | 3,239,642 | 5,750,000 |
Rights outstanding | 6,016,125 | 6,016,125 | |
Warrants expire term | 5 years | ||
Aggregate gross proceeds percentage | 60% | ||
Exercise price warrant percentage | 115% | ||
Warrant exercise price percentage (in Dollars per share) | $ 18 | ||
Series of Individually Immaterial Business Acquisitions [Member] | |||
Stockholders’ Deficit [Line Items] | |||
Business Acquisition Share Price (in Dollars per share) | $ 9.2 | ||
Warrant [Member] | |||
Stockholders’ Deficit [Line Items] | |||
Rights outstanding | 6,016,125 | 6,016,125 | |
Redeemable warrant price (in Dollars per share) | $ 11.5 | ||
Exercise price warrant percentage | 180% | ||
Price per warrant (in Dollars per share) | $ 0.01 | ||
Common stock equals or exceed per share (in Dollars per share) | 18 | ||
Warrant [Member] | Series of Individually Immaterial Business Acquisitions [Member] | |||
Stockholders’ Deficit [Line Items] | |||
Business Acquisition Share Price (in Dollars per share) | $ 9.2 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - Schedule of Fair Value on a Recurring Basis - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
Assets | ||
Marketable securities held in Trust Account | $ 35,627,550 | $ 34,959,697 |
Quoted Prices in Active Markets (Level 1) [Member] | ||
Assets | ||
Marketable securities held in Trust Account | 35,627,550 | 34,959,697 |
Significant Other Observable Inputs (Level 2) [Member] | ||
Assets | ||
Marketable securities held in Trust Account | ||
Significant Other Unobservable Inputs (Level 3) [Member] | ||
Assets | ||
Marketable securities held in Trust Account |
Promissory Notes to Big Tree _2
Promissory Notes to Big Tree Cloud (Details) - Big Tree Cloud [Member] | 3 Months Ended |
Mar. 31, 2024 USD ($) $ / shares shares | |
Promissory Notes to Big Tree Cloud [Line Items] | |
Promissory notes | $ 210,000 |
Promissory note [Member] | |
Promissory Notes to Big Tree Cloud [Line Items] | |
Promissory notes | $ 210,000 |
Common Stock [Member] | |
Promissory Notes to Big Tree Cloud [Line Items] | |
Convert into promissory note (in Shares) | shares | 25,200 |
Price per share (in Dollars per share) | $ / shares | $ 8.33 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) | 3 Months Ended | |||
May 15, 2024 | Apr. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023 | |
Subsequent Event [Line Items] | ||||
Net tangible assets | $ 5,000,001 | |||
Company’s trust account | $ 35,627,550 | $ 34,959,697 | ||
Price per public share (in Dollars per share) | $ 10.175 | |||
Big Tree Cloud [Member] | ||||
Subsequent Event [Line Items] | ||||
Promissory note | $ 210,000 | |||
Promissory Note [Member] | Big Tree Cloud [Member] | ||||
Subsequent Event [Line Items] | ||||
Promissory note | $ 210,000 | |||
Subsequent Event [Member] | ||||
Subsequent Event [Line Items] | ||||
Percentage common stock | 20% | |||
Deposited into the trust account | $ 210,000 | |||
Subsequent Event [Member] | Big Tree Cloud [Member] | ||||
Subsequent Event [Line Items] | ||||
Promissory note | 210,000 | |||
Subsequent Event [Member] | Promissory Note [Member] | Big Tree Cloud [Member] | ||||
Subsequent Event [Line Items] | ||||
Promissory note | $ 210,000 | |||
Common Stock [Member] | Big Tree Cloud [Member] | ||||
Subsequent Event [Line Items] | ||||
Price per public share (in Dollars per share) | $ 8.33 | |||
Common Stock [Member] | Subsequent Event [Member] | Big Tree Cloud [Member] | ||||
Subsequent Event [Line Items] | ||||
Convert promissory note (in Shares) | 25,200 | |||
Price per public share (in Dollars per share) | $ 8.33 | |||
Plutonian [Member] | ||||
Subsequent Event [Line Items] | ||||
Common stock shares (in Shares) | 3,172,908 | |||
Net tangible assets | $ 5,000,001 | |||
Company’s trust account | $ 34,700,000 | |||
Price per share (in Dollars per share) | $ 10.95 | |||
Common stock outstanding (in Shares) | 1,827,859 | |||
Plutonian [Member] | Subsequent Event [Member] | ||||
Subsequent Event [Line Items] | ||||
Common stock shares (in Shares) | 3,428,535 | |||
Percentage common stock | 68.60% |